Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
STRN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SH3TC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPMT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
H2AFV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFT27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTSB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
STAT6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACAA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NORAD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
RASSF4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STK25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NMNAT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MARK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM229B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6513 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on